105 related articles for article (PubMed ID: 22883117)
1. [Main clinical features and prognosis of AIDS patients with the predominance of thrombocytopenia].
Wubuli M; Pan KJ; Sun XF; Aibaidula Y; Zhang YX
Zhonghua Yi Xue Za Zhi; 2012 May; 92(19):1314-6. PubMed ID: 22883117
[TBL] [Abstract][Full Text] [Related]
2. HIV infection and AIDS.
Lloyd A
P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, severity, and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy.
Vannappagari V; Nkhoma ET; Atashili J; Laurent SS; Zhao H
Platelets; 2011; 22(8):611-8. PubMed ID: 21612330
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
[TBL] [Abstract][Full Text] [Related]
5. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
6. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations of treatment-naive patients with acquired immunodeficiency syndrome and responses to highly active antiretroviral therapy in the Taipei Veterans General Hospital: a 5-year prospective study.
Hsu SF; Yang SP; Chan YJ; Wang YW
J Microbiol Immunol Infect; 2011 Jun; 44(3):198-203. PubMed ID: 21524614
[TBL] [Abstract][Full Text] [Related]
8. Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors.
Carbonara S; Fiorentino G; Serio G; Maggi P; Ingravallo G; Monno L; Bruno F; Coppola S; Pastore G; Angarano G
J Infect; 2001 May; 42(4):251-6. PubMed ID: 11545567
[TBL] [Abstract][Full Text] [Related]
9. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
Gandhi T; Wei W; Amin K; Kazanjian P
Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
[TBL] [Abstract][Full Text] [Related]
10. Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.
Olawumi HO; Olatunji PO; Salami AK; Odeigah L; Iseniyi JO
Niger J Clin Pract; 2008 Dec; 11(4):312-5. PubMed ID: 19320401
[TBL] [Abstract][Full Text] [Related]
11. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
Gupta SB; Pujari SN; Joshi SR; Patel AK;
J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users.
Tarwater PM; Gallant JE; Mellors JW; Gore ME; Phair JP; Detels R; Margolick JB; Muñoz A
AIDS; 2004 Dec; 18(18):2419-23. PubMed ID: 15622318
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for diagnosis and treatment of HIV/AIDS in China (2005).
;
Chin Med J (Engl); 2006 Oct; 119(19):1589-608. PubMed ID: 17042972
[No Abstract] [Full Text] [Related]
14. Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.
Dai Y; Qiu ZF; Li TS; Han Y; Zuo LY; Xie J; Ma XJ; Liu ZY; Wang AX
Chin Med J (Engl); 2006 Oct; 119(20):1677-82. PubMed ID: 17097013
[TBL] [Abstract][Full Text] [Related]
15. Sarcoidosis after antiretroviral therapy in a patient with acquired immunodeficiency syndrome.
Gomez V; Smith PR; Burack J; Daley R; Rosa U
Clin Infect Dis; 2000 Nov; 31(5):1278-80. PubMed ID: 11073764
[TBL] [Abstract][Full Text] [Related]
16. Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients.
Wyen C; Jensen B; Hentrich M; Siehl J; Sabranski M; Esser S; Gillor D; Müller M; Van Lunzen J; Wolf T; Bogner JR; Wasmuth JC; Christ H; Fätkenheuer G; Hoffmann C
AIDS; 2012 Feb; 26(4):457-64. PubMed ID: 22112600
[TBL] [Abstract][Full Text] [Related]
17. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
Ho C; Lee S; Wong Kh; Cheng L; Lam M
HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of HIV-related immune thrombocytopenia.
Aboolian A; Ricci M; Shapiro K; Connors A; LaRaja RD
Int Surg; 1999; 84(1):81-5. PubMed ID: 10421025
[TBL] [Abstract][Full Text] [Related]
19. Initiation of antiretroviral therapy: implications of recent findings.
Saag MS
Top HIV Med; 2004; 12(3):83-8. PubMed ID: 15310939
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics of highly active antiretroviral therapy-associated immune reconstruction inflammation in acquired immunodeficiency syndrome].
Liu M; Zheng YH; Zhou GQ; Zhou HY; Chen Z; He Y; Chen X; Zheng LW; Jia L; He M
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):304-8. PubMed ID: 21419003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]